134 related articles for article (PubMed ID: 16437401)
1. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Golan H; Volkov O; Linchinsky O; Melloul M
Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
Lu Y; Fleming SE; Fields RC; Coit DG; Carrasquillo JA
Clin Nucl Med; 2012 Aug; 37(8):759-62. PubMed ID: 22785503
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Yao M; Smith RB; Hoffman HT; Funk GF; Graham MM; Buatti JM
Am J Clin Oncol; 2005 Apr; 28(2):205-10. PubMed ID: 15803018
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
Ishiyama M; Behnia F; Vesselle H
AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
[No Abstract] [Full Text] [Related]
7. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
[TBL] [Abstract][Full Text] [Related]
8. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
9. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Epstude M; Tornquist K; Riklin C; di Lenardo F; Winterhalder R; Hug U; Strobel K
Clin Nucl Med; 2013 Apr; 38(4):283-4. PubMed ID: 23429397
[TBL] [Abstract][Full Text] [Related]
12. Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
Yanagawa T; Shinozaki T; Iizuka Y; Takagishi K; Watanabe H
J Bone Joint Surg Br; 2010 Mar; 92(3):419-23. PubMed ID: 20190315
[TBL] [Abstract][Full Text] [Related]
13. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
14. PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma.
Lampreave JL; Bénard F; Alavi A; Jimenez-Hoyuela J; Fraker D
J Nucl Med; 1998 Dec; 39(12):2087-90. PubMed ID: 9867147
[TBL] [Abstract][Full Text] [Related]
15. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
[TBL] [Abstract][Full Text] [Related]
16. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Vadrucci M; Gilardi L; Crivelli F; Baroli A; Lomuscio G
Clin Nucl Med; 2016 Dec; 41(12):e525-e526. PubMed ID: 27824328
[TBL] [Abstract][Full Text] [Related]
18. AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.
Clapp AJ; Peller PJ; Subramaniam RM
AJR Am J Roentgenol; 2011 Jun; 196(6 Suppl):WS83-5. PubMed ID: 21606246
[No Abstract] [Full Text] [Related]
19. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
20. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
